In Silico: Analysis of the Potential of Bromelain, Zingibain and Papain as an Alternative Medicine for Fungal Keratitis

Main Article Content

Nugraha Wahyu Cahyana

Abstract

Background: Fungal keratitis is an acute or chronic inflammation of the cornea caused by fungi. The main treatment for fungal keratitis is Natamycin 5%. Disadvantages of natamycin are its poor penetration and increased resistance due to fungi which lower the level of ergosterol in its wall.


Purpose: Investigates the effect of bromelain, zingibain and papain on LOX-1 receptors in fungal keratitis caused by Aspergillus fumigatus.


Result: The LOX-1 receptor with bromelain produces a binding energy value of -827.8. While the results of docking LOX-1 receptors with zingibain resulted in a binding energy value of -1096.3. Furthermore, the results of docking the LOX-1 receptor with papain resulted in a binding energy value of -900.0.


Conclusion: zingibain has the highest potency among the three enzymes Papain as an Alternative Medicine for Fungal Keratitis

Article Details

How to Cite
Cahyana, N. W. (2022). In Silico: Analysis of the Potential of Bromelain, Zingibain and Papain as an Alternative Medicine for Fungal Keratitis. International Journal of Pharmaceutical and Bio Medical Science, 2(12), 601–607. https://doi.org/10.47191/ijpbms/v2-i12-05
Section
Articles

References

I. Goel Insan, N., V. Mane, B. L. Chaudhary, M. Singh Danu, A. Yadav, dan V. Srivastava. 2013. A review of fungal keratitis: etiology and laboratory diagnosis. International Journal of Current Microbiology and Applied Sciences. 2(6):307–314.

II. Niu, L., X. Liu, Z. Ma, Y. Yin, L. Sun, L. Yang, dan Y. Zheng. 2020. Fungal keratitis: pathogenesis, diagnosis and prevention. Microbial Pathogenesis. 138(April 2019)

III. Brown, L., A. K. Leck, M. Gichangi, M. J. Burton, dan D. W. Denning. 2021. The global incidence and diagnosis of fungal keratitis. The Lancet Infectious Diseases. 21(3):e49–e57.

IV. Lalitha, P., N. V. Prajna, A. Kabra, K. Mahadevan, dan M. Srinivasan. 2006. Risk factors for treatment outcome in fungal keratitis. 526–530.

V. Sarika, D. T., M. Louisa, A. Rozaliyani, dan M. Susiyanti. 2021. Efficacy of adjuvant intrastromal and combination of intrastromal and intracameral voriconazole in aspergillus fumigatus-induced moderate fungal keratitis in rabbits. Medical Journal of Indonesia. 30(1):13–19.

VI. Hoffman, J. J., M. J. Burton, dan A. Leck. 2021. Mycotic keratitis—a global threat from the filamentous fungi. Journal of Fungi. 7(4):1–36.

VII. Raj, N., M. Vanathi, N. H. Ahmed, N. Gupta, N. Lomi, dan R. Tandon. 2021. Recent perspectives in the management of fungal keratitis. Journal of Fungi. 7(11)

VIII. Gao, X., G. Zhao, C. Li, J. Lin, N. Jiang, Q. Wang, L. Hu, Q. Xu, X. Peng, K. He, dan G. Zhu. 2016. LOX-1 and tlr4 affect each other and regulate the generation of ros in a. fumigatus keratitis. International Immunopharmacology. 40:392–399.

IX. Jiang, J. Q., C. Li, C. X. Cui, Y. N. Ma, G. Q. Zhao, X. D. Peng, Q. Xu, Q. Wang, G. Q. Zhu, dan C. Y. Li. 2019. Inhibition of lox-1 alleviates the proinflammatory effects of high-mobility group box 1 in aspergillus fumigatus keratitis. International Journal of Ophthalmology. 12(6):898–903.

X. Abreu, D. C. A. and K. C. S. De Figueiredo. 2019. Bromelain separation and purification processes from pineapple extract. Brazilian Journal of Chemical Engineering. 36(2):1029–1039.

XI. Hikisz, P. dan J. Bernasinska-Slomczewska. 2021. Beneficial properties of bromelain. Nutrients. 13(12)

XII. Chakraborty, A. J., S. Mitra, T. E. Tallei, A. M. Tareq, F. Nainu, D. Cicia, K. Dhama, T. Bin Emran, J. Simal-Gandara, dan R. Capasso. 2021. Bromelain a potential bioactive compound: a comprehensive overview from a pharmacological perspective. Life. 11(4):1–26.

XIII. Rathnavelu, V., N. B. Alitheen, S. Sohila, S. Kanagesan, dan R. Ramesh. 2016. Potential role of bromelain in clinical and therapeutic applications (review). Biomedical Reports. 5(3):283–288.

XIV. Nafi’ A, H.L Foo, B. Jamilah, dan H.M Ghazali. 2013 Properties of proteolytic enzyme from ginger (Zingiber officinale Roscoe). Int Food Res J. 20(1):3–8.

XV. Prima P., B. Pairul, S.H. Nasution. 2017. Jahe ( Zingiber Officinale ) Sebagai Anti Ulserogenik Ginger ( Zingiber Officinale ) as Anti Ulcerogenic. 7:42–6.

XVI. Amri, E. and F. Mamboya. 2012. Papain, a plant enzyme of biological importance: a review. American Journal of Biochemistry and Biotechnology. 8(2):99–104.

XVII. Ahmadikia, K., S. Aghaei Gharehbolagh, B. Fallah, M. Naeimi Eshkaleti, P. Malekifar, S. Rahsepar, M. I. Getso, S. Sharma, dan S. Mahmoudi. 2021. Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020). Frontiers in Cellular and Infection Microbiology. 11(August):1–12.

XVIII. Mahmoudi, S., A. Masoomi, K. Ahmadikia, S. A. Tabatabaei, M. Soleimani, S. Rezaie, H. Ghahvechian, dan A. Banafsheafshan. 2018. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses. 61(12):916–930.

XIX. Kuo, M. T., S. L. Hsu, H. L. You, S. F. Kuo, A. Chen, C. Y. Tseng, Y. H. Lai, J.L. Chen, P. C. Fang, dan H. J. Yu. 2022. Diagnosing fungal keratitis and simultaneously identifying fusarium and aspergillus keratitis with a dot hybridization array. Journal of Fungi. 8(1)

XX. Mills, B., N. Radhakrishnan, S. G. Karthikeyan Rajapandian, G. Rameshkumar, P. Lalitha, dan N. V. Prajna. 2021. The role of fungi in fungal keratitis. Experimental Eye Research. 202(November 2020)

XXI. Sadik, N., S. M. Elzeiny, Y. E. Ali, dan D. Sobeih. 2022. Fungal keratitis in the egyptian delta: epidemiology, risk factors, and microbiological diagnosis. Ophthalmic Epidemiology. 29(2):198–205.

XXII. Chongkae, S., S. Youngchim, J. D. Nosanchuk, A. Laliam, C. Tangmonkongvoragul, dan K. Pruksaphon. 2021. Fungal keratitis in northern thailand: spectrum of agents, risk factors and putative virulence factors. Journal of Fungi. 7(6)

XXIII. Bourcier, T., A. Sauer, A. Dory, J. Denis, dan M. Sabou. 2017. Fungal keratitis. Journal Francais d’Ophtalmologie. 40(9):e307–e313.

XXIV. Chen, C. A., S. L. Hsu, C. H. Hsiao, D. H. K. Ma, C. C. Sun, H. J. Yu, P. C. Fang, and M. T. Kuo. 2020. Comparison of fungal and bacterial keratitis between tropical and subtropical taiwan: a prospective cohort study. Annals of Clinical Microbiology and Antimicrobials. 19(1):1–8.

XXV. Ghosh, A. K., A. Gupta, S. M. Rudramurthy, S. Paul, V. K. Hallur, dan A. Chakrabarti. 2016. Fungal keratitis in north india: spectrum of agents, risk factors and treatment. Mycopathologia. 181(11–12):843–850.

XXVI. Harbiyeli, İ. İ., E. Erdem, N. Görkemli, A. İbayev, H. Kandemir, A. Açıkalın, M. İlkit, dan M. Yağmur. 2022. Clinical and mycological features of fungal keratitis: a retrospective single-center study (2012-2018). Turkish Journal of Ophthalmology. 52(2):75–85.

XXVII. Leck, A. and M. Burton. 2015. Distinguishing fungal and bacterial keratitis on clinical signs. Community Eye Health Journal. 28(89):6–7.

XXVIII. Tananuvat, N., P. Upaphong, C. Tangmonkongvoragul, M. Niparugs, W. Chaidaroon, dan M. Pongpom. 2021. Fungal keratitis at a tertiary eye care in northern thailand: etiology and prognostic factors for treatment outcomes. Journal of Infection. 83(1):112–118.

XXIX. Austin, A., T. Lietman, dan J. Rose-Nussbaumer. 2017. Update on the management of infectious keratitis. Ophthalmology. 124(11):1678–1689.

XXX. Solanki, S., M. Rathi, S. Khanduja, C. S. Dhull, S. Sachdeva, dan J. Phogat. 2015. Recent trends: medical management of infectious keratitis. Oman Journal of Ophthalmology. 8(2):83–85.

XXXI. Pavan, R., S. Jain, Shraddha, dan A. Kumar. 2012. Properties and therapeutic application of bromelain: a review. Biotechnology Research International. 2012(December):1–6.

XXXII. Abreu, D. C. A. and K. C. S. De Figueiredo. 2019. Bromelain separation and purification processes from pineapple extract. Brazilian Journal of Chemical Engineering. 36(2):1029–1039.

XXXIII. Chakraborty, A. J., S. Mitra, T. E. Tallei, A. M. Tareq, F. Nainu, D. Cicia, K. Dhama, T. Bin Emran, J. Simal-Gandara, dan R. Capasso. 2021. Bromelain a potential bioactive compound: a comprehensive overview from a pharmacological perspective. Life. 11(4):1–26.

XXXIV. Ghasemzadeh, A., H.Z. Jaafar, A. Rahmat. 2010. Antioxidant activities, total phenolics and flavonoids content in two varieties of Malaysia young ginger (Zingiber. officinale Roscoe). Molecules. 12:4324–4333.

XXXV. Amri E., dan F. Mamboya. 2012. Papain A Plant Enzyme of Biological Importance. American Journal of Biochemistry and Biotechnology. 8(2) : 99-104